According to Portage Biotech's latest financial reports the company's current EPS (TTM) is -$6.67. In 2022 the company made an earnings per share (EPS) of -$1.18 an increase over its 2021 EPS that were of -$1.71.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$6.67 | 465.25% |
2022 | -$1.18 | -30.99% |
2021 | -$1.71 | 248.98% |
2020 | -$0.49 | -10.45% |
2019 | -$0.55 | -101.18% |
2018 | $46.34 | -1155.76% |
2017 | -$4.39 | -143.89% |
2016 | $10.00 | -460.53% |
2015 | -$2.77 | 29.28% |
2014 | -$2.15 | -33.33% |
2013 | -$3.22 | 35.17% |
2012 | -$2.38 | -36.2% |
2011 | -$3.73 | -58.05% |
2010 | -$8.90 | 99.91% |
2009 | -$4.45 | 497.14% |
2008 | -$0.75 | 52.91% |
2007 | -$0.49 | -50.68% |
2006 | -$0.99 | -98.26% |
2005 | -$56.76 | -522.45% |
2004 | $13.44 | 30.7% |
2003 | $10.28 | -130.44% |
2002 | -$33.77 | -123.54% |
2001 | $143.48 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | -$0.06000 | -99.10% | Bahamas |
NRC Health
NRC | $1.19 | -117.84% | ๐บ๐ธ USA |